The latest price target for DexCom (NASDAQ:DXCM) was reported by Baird on January 16, 2025. The analyst firm set a price target for $104.00 expecting DXCM to rise to within 12 months (a possible 18.60% upside). 37 analyst firms have reported ratings in the last year.

The latest analyst rating for DexCom (NASDAQ:DXCM) was provided by Baird, and DexCom upgraded their outperform rating.

The last upgrade for DexCom Inc happened on January 16, 2025 when Baird raised their price target to $104. Baird previously had a neutral for DexCom Inc.

The last downgrade for DexCom Inc happened on July 26, 2024 when Baird changed their price target from $161 to $80 for DexCom Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DexCom, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DexCom was filed on January 16, 2025 so you should expect the next rating to be made available sometime around January 16, 2026.

While ratings are subjective and will change, the latest DexCom (DXCM) rating was a upgraded with a price target of $86.00 to $104.00. The current price DexCom (DXCM) is trading at is $87.69, which is within the analyst’s predicted range.